JHC
OLMA icon

Jones Hill Capital’s Olema Pharmaceuticals OLMA Stock Holding History

Jones Hill Capital’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.18M Buy
+574,166
New +$7.69M 1.53% 21

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Jones Hill Capital's OLMA Position: Q2 2026 in Review

Jones Hill Capital opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 574,166 shares worth $7.18M. The stake represents 1.53% of the portfolio and ranks #21 among its holdings.

182 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Jones Hill Capital held 574,166 shares of Olema Pharmaceuticals worth $7.18M as of Q2 2026.
  • Olema Pharmaceuticals was a new Jones Hill Capital position in Q2 2026.
  • Olema Pharmaceuticals made up 1.53% of Jones Hill Capital's portfolio in Q2 2026, its #21 holding.
  • 182 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Jones Hill Capital's 13F filing for Q2 2026, filed 13 Aug 2026.